Gontjes K, Gibson K, Lansing B, Cassone M, Mody L
Infect Control Hosp Epidemiol. 2021; 43(8):1063-1066.
PMID: 34016196
PMC: 9190292.
DOI: 10.1017/ice.2021.134.
Weterings V, Van Oosten A, Nieuwkoop E, Nelson J, Voss A, Wintermans B
Antimicrob Resist Infect Control. 2021; 10(1):38.
PMID: 33602300
PMC: 7893727.
DOI: 10.1186/s13756-021-00906-x.
Khader K, Thomas A, Huskins W, Leecaster M, Zhang Y, Greene T
Open Forum Infect Dis. 2017; 4(1):ofw247.
PMID: 28702465
PMC: 5499871.
DOI: 10.1093/ofid/ofw247.
Richter S, Marchaim D
Virulence. 2016; 8(4):417-426.
PMID: 27813699
PMC: 5477693.
DOI: 10.1080/21505594.2016.1255381.
Mckinnell J, Kunz D, Moser S, Vangala S, Tseng C, Shapiro M
Epidemiol Infect. 2016; 144(8):1748-55.
PMID: 27125574
PMC: 5943038.
DOI: 10.1017/S0950268815003118.
Vancomycin-resistant enterococci colonization in patients with hematological malignancies: screening and its cost-effectiveness.
Gedik H, Simsek F, Kanturk A, Yildirmak T, Arica D, Aydin D
Afr Health Sci. 2015; 14(4):899-905.
PMID: 25834499
PMC: 4370069.
DOI: 10.4314/ahs.v14i4.18.
Comparison of five chromogenic media for recovery of vancomycin-resistant enterococci from fecal samples.
Suwantarat N, Roberts A, Prestridge J, Seeley R, Speser S, Harmon C
J Clin Microbiol. 2014; 52(11):4039-42.
PMID: 25143571
PMC: 4313247.
DOI: 10.1128/JCM.00151-14.
Duration of colonization with antimicrobial-resistant bacteria after ICU discharge.
Haverkate M, Derde L, Brun-Buisson C, Bonten M, Bootsma M
Intensive Care Med. 2014; 40(4):564-71.
PMID: 24522879
PMC: 3969519.
DOI: 10.1007/s00134-014-3225-8.
Comparison of perirectal versus rectal swabs for detection of asymptomatic carriers of toxigenic Clostridium difficile.
Rogers D, Kundrapu S, Sunkesula V, Donskey C
J Clin Microbiol. 2013; 51(10):3421-2.
PMID: 23926162
PMC: 3811660.
DOI: 10.1128/JCM.01418-13.
Nasal and perirectal colonization of vancomycin sensitive and resistant enterococci in patients of paediatrics ICU (PICU) of tertiary health care facilities.
Yameen M, Iram S, Mannan A, Khan S, Akhtar N
BMC Infect Dis. 2013; 13:156.
PMID: 23536967
PMC: 3621148.
DOI: 10.1186/1471-2334-13-156.
Sources of systematic errors in the epidemiology of vancomycin-resistant enterococci.
Mutters N, Frank U
Infection. 2013; 41(2):305-10.
PMID: 23386219
DOI: 10.1007/s15010-013-0410-6.
Prevalence and risk factors for VRE colonisation in a tertiary hospital in Melbourne, Australia: a cross sectional study.
Karki S, Houston L, Land G, Bass P, Kehoe R, Borrell S
Antimicrob Resist Infect Control. 2012; 1(1):31.
PMID: 23039285
PMC: 3523023.
DOI: 10.1186/2047-2994-1-31.
Surveillance cultures and duration of carriage of multidrug-resistant Acinetobacter baumannii.
Marchaim D, Navon-Venezia S, Schwartz D, Tarabeia J, Fefer I, Schwaber M
J Clin Microbiol. 2007; 45(5):1551-5.
PMID: 17314222
PMC: 1865886.
DOI: 10.1128/JCM.02424-06.
Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infections.
DiNubile M, Chow J, Satishchandran V, Polis A, Motyl M, Abramson M
Antimicrob Agents Chemother. 2005; 49(8):3217-21.
PMID: 16048928
PMC: 1196251.
DOI: 10.1128/AAC.49.8.3217-3221.2005.
Test characteristics of perirectal and rectal swab compared to stool sample for detection of fluoroquinolone-resistant Escherichia coli in the gastrointestinal tract.
Lautenbach E, Harris A, Perencevich E, Nachamkin I, Tolomeo P, Metlay J
Antimicrob Agents Chemother. 2005; 49(2):798-800.
PMID: 15673772
PMC: 547369.
DOI: 10.1128/AAC.49.2.798-800.2005.
Vancomycin-resistant enterococci.
Cetinkaya Y, Falk P, Mayhall C
Clin Microbiol Rev. 2000; 13(4):686-707.
PMID: 11023964
PMC: 88957.
DOI: 10.1128/CMR.13.4.686.